Arnaud Lacour

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

Multicentre Study, Pharmacology, Medicine +3

An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A

Shahram Attarian, Jean‐Michel Vallat, Laurent Magy et al. · Orphanet Journal of Rare Diseases · 2014 · 124 citations · Full text

Anti-MAG antibodies in 202 patients: clinicopathological and therapeutic features

Juliette Svahn, Philippe Petiot, Jean‐Christophe Antoine et al. · Journal of Neurology Neurosurgery & Psychiatry · 2017 · 103 citations

Morphologic imaging in muscular dystrophies and inflammatory myopathies

Adrian Degardin, David Morillon, Arnaud Lacour et al. · Skeletal Radiology · 2010 · 91 citations

Morphologic Imaging, Medical Imaging, Medicine +5

Clinical outcome in 19 French and Spanish patients with valosin-containing protein myopathy associated with Paget’s disease of bone and frontotemporal dementia

Tanya Stojkovic, El Hadi Hammouda, Pascale Richard et al. · Neuromuscular Disorders · 2009 · 84 citations

Dementia, Valosin-containing Protein Myopathy, Spanish Patients +7